GNF-6231
CAS: 1243245-18-2
Ref. 3D-TZB24518
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
GNF-6231 is a small molecule that inhibits the transcriptional regulator β-catenin, which is involved in the Wnt pathway. GNF-6231 has been shown to inhibit colorectal carcinoma growth and metastasis, as well as induce cardiac and ventricular dysfunction in mice. It also inhibits hepatocellular carcinoma growth and metastasis in mice. The drug can be used to treat cancer by inhibiting the progression of cancer cells. This drug has been shown to be effective against monoclonal antibodies against β-catenin, including cetuximab, which is used to treat colorectal carcinoma.
Chemical properties
Technical inquiry about: 3D-TZB24518 GNF-6231
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
